
Selective Glycopolymer Inhibitors of Galectin-3: Supportive Anti-Cancer Agents Protecting Monocytes and Preserving ...
Introduction The efficacy of current clinical cancer immunotherapies is severely limited by the immunosuppressive tumor microenvironment (TME), in which tumor monocytes play an important role. As the most common type of immune cells in solid tumors,1 …